Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 960-965

  Chung, W K ^a,b   Zheng, Z L ^a   Sung, J Y ^a   Kim, S ^a   Lee, H H ^a   Choi, S J ^a   Yang, J ^a,b,c  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Cancer Research Center   (South Korea)

Author keywords

BCG; Haemodialysis; Immunocompromised; Interferon release assays; Latent tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SOUTH KOREA; TUBERCULIN TEST; TUBERCULOSIS; VALIDATION PROCESS;

EID: 77954639444     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02949.x     Document Type: Article

References (20)

1. Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM. Tuberculosis in maintenance dialysis patients. Nephron 2001, 88:138-143.
2. Rose DN. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 2000, 160:1513-1521.
3. Tuberculosis transmission in a renal dialysis center-Nevada, 2003. MMWR Morb Mortal Wkly Rep 2004, 53:873-875.
4. Sester M, Sester U, Clauer P. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004, 65:1826-1834.
5. Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008, 67:84-90.
6. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
7. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille calmette guerin vaccination on tuberculin skin test measurements. Thorax 2002, 57:804-809.
8. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004, 4:761-776.
9. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-spot.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007, 2:68-73.
10. Winthrop KL, Nyendak M, Calvet H. Interferon-{gamma} release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008, 3:1357-1363.
11. Im JG, Itoh H, Shim YS. Pulmonary tuberculosis: Ct findings-early active disease and sequential change with antituberculous therapy. Radiology 1993, 186:653-660.
12. Manuel O, Humar A, Preiksaitis J. Comparison of quantiferon-tb gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007, 7:2797-2801.
13. Lee JY, Choi HJ, Park IN. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28:24-30.
14. Kang YA, Lee HW, Yoon HI. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756-2761.
15. Park IN, Hong SB, Oh YM. Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis. Int J Tuberc Lung Dis 2007, 11:319-324.
16. Mandalakas AM, Hesseling AC, Chegou NN. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008, 12:417-423.
17. Ferrara G, Losi M, D'Amico R. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328-1334.
18. Eleftheriadis T, Tsiaga P, Antoniadi G. The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis 2005, 46:706-712.
19. Section iv: Long-term management of the transplant recipient. Iv.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002, 17(suppl 4):39-43.
20. Visweswaran RK. What is the best way of screening hemodialysis patients for latent tuberculosis? Nat Clin Pract Nephrol 2007, 3:310-311.